Attard, G. et al. (2014) Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. European Urology, 66(5), pp. 799-802. (doi: 10.1016/j.eururo.2014.05.038)
|
Text
100363.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 1MB |
Publisher's URL: http://dx.doi.org/10.1016/j.eururo.2014.05.038
Abstract
No abstract available.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Russell, Dr Martin |
Authors: | Attard, G., Sydes, M. R., Mason, M. D., Clarke, N. W., Aebersold, D., de Bono, J. S., Dearnaley, D. P., Parker, C. C., Ritchie, A. W.S., Russell, J. M., Thalmann, G., Cassoly, E., Millman, R., Matheson, D., Schiavone, F., Spears, M. R., Parmar, M. K.B., and James, N. D. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | European Urology |
Publisher: | Elsevier |
ISSN: | 0302-2838 |
ISSN (Online): | 1873-7560 |
Copyright Holders: | Copyright © 2014 European Association of Urology |
First Published: | First published in European Urology 66(5):799-802 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record